ArticleWorld journal of microbiology & biotechnology2025
Accelerated detection of carbapenem resistance in Klebsiella pneumoniae via single-cell Raman spectroscopy.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stringent Response Regulates the Persister Formation and Virulence ofMicroorganisms · 2026Article
- Recent Advances in Understanding the Clinical Implications of Heterogeneous Drug Resistance inInfection and drug resistance · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Antibiotic resistance poses a significant global public health challenge, particularly concerning carbapenem-resistant Klebsiella pneumoniae (CRKP). A Raman-based antimicrobial susceptibility testing (R-AST) method was developed, utilizing D₂O-labeled single-cell Raman spectroscopy alongside the Metabolic Inhibition Level (MIL) for rapid CRKP antimicrobial susceptibility testing and carbapenemase enzyme typing. By analyzing 30,000 single-cell Raman spectra from 57 K. pneumoniae strains, the R-AST accurately detected CRKP within two hours. Furthermore, R-AST was able to differentiate between amikacin-sensitive and amikacin-resistant strains within the CRKP category, thereby providing potential treatment options. Notably, both R-AST classifications demonstrated 100% category agreement with the Vitek
Indexed as
Identifiers
40299234What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.